Newsroom

News

The European Research Council (ERC) has announced the results of the latest round of its “Proof of Concept Grant” 2024 competition. Among the researchers selected for funding is Prof. Yang Li, co-director of the Centre for Individualised Infection Medicine (CiiM) and head of the research department “Bioinformatics for Individualised Medicine”, who has thus been awarded one of the coveted ERC grants for the second time. In total, the ERC selected 134 projects for funding of 150,000 euros each. The CiiM is a branch of the Helmholtz Centre for Infection Research (HZI), which is operated jointly with the Hannover Medical School (MHH).

29.01.2025

CiiM

News

The long-standing President of the Thünen Institute, Prof. Dr Folkhard Isermeyer, passed away on 14 January 2025 at the age of 67. With his passing, the Thünen Institute has not only lost its ‘architect’, an excellent scientist and clever strategist, but also a personality who led with trust, an open ear and human warmth.

23.01.2025

Group picture with about 20 people from the consortium

News

With viral disease emergence expected to accelerate, preparing for possible future pandemics is paramount. Beyond saving lives during outbreaks, robust pandemic preparedness safeguards economies, sustains societal functioning, and reinforces the resilience of global systems. The new EU project COMBINE (“Comparative Signature of Marburg Virus Cell Activation as a Blueprint for the Identification of Antiviral Targets against Newly Emerging Viruses”) acknowledges that understanding how viruses infiltrate host cells is crucial to combating emerging infectious diseases. The project sets out to advance our understanding of how viruses enter cells, using the Marburg Virus (MARV) as a model, and to create a blueprint for identifying new targets for antiviral strategies – a critical cornerstone of pandemic preparedness. Coordinated by the German Helmholtz Centre for Infection Research (HZI), COMBINE brings together seven partners from five European countries and will receive a total funding of 7.2 million euros over the next five years through the European Union’s “Horizon Europe” Framework Programme for Research and Innovation.

21.01.2025

HZI Campus

News

A hospital is a place where you generally don't like to go, but are glad that it's there when you need it. It's called ‘clinically clean’. But it is precisely here that we also encounter the term “hospital germ” – an ominous reminder that a place of healing can also pose a health risk. These pathogenic germs are often so resilient that only a few drugs are effective against them. Prof. Susanne Häußler, head of the department “Molecular Bacteriology” at the HZI and TWINCORE in Hannover, studies how these multi-resistant bacteria develop. In the HZI podcast InFact, she explains how faster diagnostics can also improve treatment.

16.01.2025

TWINCORE

HZI Campus

News

A team of scientists at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg and the University of Regensburg has unveiled insights into how HIV-1, the virus responsible for AIDS, skillfully hijacks cellular machinery for its own survival. By dissecting the molecular interplay between the virus and its host, the researchers identified novel strategies that HIV-1 employs to ensure its replication while suppressing the host’s cellular defenses. The study was published in the journal Nature Structural and Molecular Biology.

16.01.2025

HIRI

News

Antibiotics are a double-edged sword – they should be as toxic as possible to pathogenic bacteria while being harmless to the cells of the human body. An international research team led by the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) has now developed drug candidates that achieve precisely that. The new molecules target a metabolic pathway that only occurs in bacterial cells, thus sparing human cells. The team published its results in the journal Angewandte Chemie International Edition.

13.01.2025

HIPS

Back to the first page
...
13
14
15
16
...
149

HZI in the media

Klett-Tammen, Abteilung Epidemiologie (EPID), Helmholtz-Zentrum für Infektionsforschung (

HZI

), Braunschweig. Grundsätzlich sei auch die ...

13.11.2025

Deutsches Ärzteblatt

von Angios in Innsbruck & wissenschaftlicher Geschäftsführer Helmholtz-Zentrum für Infektionsforschung in Braunschweig/Deutschland), Klaus

13.11.2025

meinbezirk.at

... zu adressieren, suchen Forschende am HZI-Standort Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) im Rahmen ...

13.11.2025

Prophylaxe Journal

new antiviral medicines, says virologist Christian Sieben of the Helmholtz Centre for Infection Research in Germany.

Earlier in 2025, for

10.11.2025

The Press

Hochschule Hannover, die Universitätsmedizin Göttingen, das Helmholtz-Zentrum für Infektionsforschung in Braunschweig sowie die KI-

07.11.2025

Heise online

... , Leiter der Forschungsgruppe Mikrobielle Wirkstoffe am Helmholtz-Zentrum für Infektionsforschung, zu bedenken. Das erste ...

07.11.2025

Leipziger Volkszeitung (LVZ)

Quelle: Pressemitteilung

HZI-Helmholtz Zentrum für Infektionsforschung ...

04.11.2025

LaborPraxis

Forschende des Helmholtz-Zentrums für Infektionsforschung und der Universität Würzburg entwickeln derzeit einen Kaugummi, der Grippeviren

04.11.2025

Arbeitsmedizin-Sozialmedizin-Umweltmedizin

... Vakzinologie und angewandte Mikrobiologie am Helmholtz-Zentrum für Infektionsforschung. Die M2-Membranproteinhemmer verhindern ...

02.11.2025

Augsburger Allgemeine

... etwas dran ist“, erklärt Biologe Marc Stadler vom Helmholtz-Zentrum für Infektionsforschung gegenüber der Barmer-Krankenkasse. „Es ...

30.10.2025

bild der wissenschaft

could be reintroduced at any time. Epidemiologists at the Helmholtz Center for Infection Research (HZI) have now shown that many people do

23.10.2025

MSN.com

... eingeschleppt werden könnte. Epidemiolog:innen des Helmholtz-Zentrums für Infektionsforschung (HZI) haben nun gezeigt, dass ...

23.10.2025

innovations report

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.